About JILIN CHANGLONG Company

Jilin Huinan Changlong Biochemical Pharmaceutical Co., Ltd. is located at the foot of the beautiful and rich Changbai Mountain. In the Huinan Economic Development Zone Pharmaceutical Industrial Park in Tonghua, a famous pharmaceutical city in the country. The company was founded in 1989 and is a key enterprise in the pharmaceutical industry in Jilin Province. It was named “Excellent Enterprise” and “Outstanding Contributing Enterprise” by the provincial government. It was recognized as a high-tech enterprise by the Provincial Science and Technology Commission in 1999, and was the first modern pharmaceutical enterprise in Jilin Province to fully pass the national GMP certification in 2000. In 2001, it was recognized by the Ministry of Science and Technology as a national key high-tech enterprise and a key enterprise in the biomedical industry base of the National Torch Program. The company's shares were listed in Hong Kong in the same year. Over the past 20 years, it has been strictly regulated and managed in accordance with the “Company Law”, and has developed into a medium-sized pharmaceutical enterprise with high efficiency, high growth, high technological content, and integrating scientific research and development, production and operation, and marketing and sales. The company has wholly-owned companies such as Changlong Distribution Company, Changlong Linxiashan Base, Changlong Hotel, and Changlong Real Estate Company. It currently has 520 employees, 238 varieties of 11 dosage forms, 10 production workshops, and all solid and injection workshops passed the new GMP certification at the end of 2014. The core product “Haikun Xinxi Capsule” has become a first-line product used in the treatment of renal failure in China. The company has provincial technical centers, quality evaluation centers, animal laboratories, process laboratories, and pilot laboratories, which are mainly engaged in the application of new drug research technology results, drug process improvement and improvement, and in-depth treatment development of existing drugs. Total assets have reached 0.7 billion yuan. In order to meet the company's development needs, it moved to the Pharmaceutical Industrial Park in Huinan Economic Development Zone in 2013, covering an area of 0.13 million square meters. The company has always adhered to the business philosophy of “technology, innovation, virtue, and benefit the world”. Follow the path of globalization and contribute to the world's human health as an unremitting effort and pursuit of the company's development. Facing the opportunities and challenges of the integration of the world economy, Changlong Pharmaceutical is like a dragon taking off with its scientific and technological talents, innovative and realistic management team, and a modern enterprise system in line with the international community. With the pomp and simplicity of the Kanto people, and the essence of Baishan resources, Changlong Pharmaceutical takes off like a dragon that takes off. It will definitely stand in the forest of Oriental Pharmaceuticals in the world and create a more brilliant tomorrow.